Insider · CIK 0001189792
KNIGHT PETER S
Reports to the SEC for 4 companies · WOODCLIFF LAKE, NJ
Transactions
50
Companies
4
Filings
6
CIK
0001189792
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-07-01 | BIAFbioAffinity Technologies, Inc.A Award | — |
| 2024-06-12 | BIAFbioAffinity Technologies, Inc.A Award | — |
| 2024-01-01 | BIAFbioAffinity Technologies, Inc.A Award | +$18.7K |
| 2023-10-01 | BIAFbioAffinity Technologies, Inc.A Award | +$18.7K |
| 2023-07-01 | BIAFbioAffinity Technologies, Inc.A Award | +$18.7K |
| 2023-04-15 | BIAFbioAffinity Technologies, Inc.A Award | +$18.7K |
| 2023-01-01 | BIAFbioAffinity Technologies, Inc.A Award | +$18.8K |
| 2022-08-31 | BIAFbioAffinity Technologies, Inc. · Non-tradeable Warrants (right to buy)P Purchase | — |
| 2022-08-31 | BIAFbioAffinity Technologies, Inc.P Purchase | — |
| 2022-08-31 | BIAFbioAffinity Technologies, Inc. · Warrants (right to buy)P Purchase | — |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$52.8K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$153K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$87.4K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$306K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$47.6K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$422K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPD Disposition to Issuer | −$551K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$104K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$172K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$318K |
| 2012-12-11 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionD Disposition to Issuer | −$309K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer | −$81.9K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer | −$39.3K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer | −$118K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Restricted Stock UnitsD Disposition to Issuer | −$1.5M |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer | −$183K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer | −$12.5K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.D Disposition to Issuer | −$175K |
| 2012-09-28 | PAR PHARMACEUTICAL COMPANIES, INC.Deferred Unit Awards/Stock UnitsD Disposition to Issuer | −$1.14M |
| 2012-08-23 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionM Exercise/Conversion | — |
| 2012-08-23 | MEDICIS PHARMACEUTICAL CORPS Sale | −$113K |
| 2012-08-23 | MEDICIS PHARMACEUTICAL CORPM Exercise/Conversion | +$71.5K |
| 2012-07-02 | PAR PHARMACEUTICAL COMPANIES, INC.Deferred Unit Award/Stock UnitsA Award | +$21.3K |
| 2012-05-15 | MEDICIS PHARMACEUTICAL CORPA Award | — |
| 2012-05-15 | MEDICIS PHARMACEUTICAL CORPNon-Employee Director OptionA Award | — |
| 2012-04-02 | PAR PHARMACEUTICAL COMPANIES, INC.Deferred Unit Award/Stock UnitsA Award | +$21.3K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$18.5K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.M Exercise/Conversion | +$216K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$22.2K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyM Exercise/Conversion | — |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$29.6K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$48.2K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$25.9K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$130K |
| 2012-03-19 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$3,703.06 |
| 2012-01-05 | PAR PHARMACEUTICAL COMPANIES, INC.Restricted Stock UnitsA Award | — |
| 2012-01-03 | PAR PHARMACEUTICAL COMPANIES, INC.Deferred Unit Award/Stock UnitsA Award | +$21.3K |
| 2011-12-15 | PAR PHARMACEUTICAL COMPANIES, INC.M Exercise/Conversion | +$74.8K |
| 2011-12-15 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$35.8K |
| 2011-12-15 | PAR PHARMACEUTICAL COMPANIES, INC.S Sale | −$3,252 |
Recent filings
- 4KNIGHT PETER S0001493152-24-026088SEC(opens sec.gov)
- 4KNIGHT PETER S0001493152-24-023996SEC(opens sec.gov)
- 4KNIGHT PETER S0001493152-24-003692SEC(opens sec.gov)
- 4KNIGHT PETER S0001493152-23-023816SEC(opens sec.gov)
- 4KNIGHT PETER S0001493152-22-034466SEC(opens sec.gov)
- 4KNIGHT PETER S0001246360-12-004840SEC(opens sec.gov)
Companies
Address
C/O PAR PHARMACEUTICAL 300 TICE BOULEVARD
WOODCLIFF LAKE, NJ, 07960